What this biotech's volatile stock price tells you about the weight loss market right now
Shares of Danish biotech Zealand Pharma recently plunged after detailed data on its weight loss drug survodutide showed far higher...
Roche Holding AG
Drugmakers race to find a place in the next wave of obesity drugs
Drugmakers are only months into introducing GLP-1 pills and navigating huge changes in how patients pay for weight-loss drugs. Even...
Switzerland is voting on whether to cap its population at 10 million. Here's what to know
A photo shows a poster depicting U.S. President Donald Trump, Russian President Vladimir Putin and Chinese President Xi Jinping and...
European stocks to open in negative territory as oil prices gain
A stock trader looks at his monitors in the trading room of the Frankfurt Stock Exchange. Worries about a new...
Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to excite
Drugmakers Roche and Sanofi's latest earnings were largely as expected, with the companies talking up the potential of experimental medicines...
Novo Nordisk enters 2026 on the defense as it faces a ‘must-win’ battle in the U.S. market
Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by: Michael Siluk/UCG/Universal Images...
Nine of the largest pharma companies ink deals with Trump to lower drug prices
US President Donald Trump during an announcement in the Roosevelt Room of the White House in Washington, DC, US, on...
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott...
